WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000061773) RECOMBINANT AND MUTANT ADENOVIRUSES DERIVED OF BOVINE ADENOVIRUS TYPE 1
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/061773    International Application No.:    PCT/US2000/009459
Publication Date: 19.10.2000 International Filing Date: 07.04.2000
Chapter 2 Demand Filed:    11.10.2000    
IPC:
C12N 15/861 (2006.01)
Applicants: SCHERING-PLOUGH LTD. [CH/CH]; Toepferstrasse 5, CH-6004 Lucerne (CH) (For All Designated States Except US).
CHIANG, Christina, H. [US/US]; (US) (For US Only).
COCHRAN, Mark, D. [US/US]; (US) (For US Only)
Inventors: CHIANG, Christina, H.; (US).
COCHRAN, Mark, D.; (US)
Agent: FOULKE, Cynthia, L.; Schering-Plough Corporation, Patent Dept., K-6-1 1990, 2000 Galloping Hill Road, Kenilworth, NJ 07033-0530 (US)
Priority Data:
09/289,930 09.04.1999 US
Title (EN) RECOMBINANT AND MUTANT ADENOVIRUSES DERIVED OF BOVINE ADENOVIRUS TYPE 1
(FR) ADENOVIRUS RECOMBINANTS ET MUTANTS DERIVES DE L'ADENOVIRUS TYPE 1 BOVIN
Abstract: front page image
(EN)The present invention provides viral vectors. In one embodiment, the present invention provides mutant and recombinant bovine adenoviruses having a deletion and/or insertion of DNA in the early gene region 4 (E4). In another embodiment, the present invention provides mutant and recombinant bovine adenovirus 1 viruses having a deletion and/or insertion of DNA in the early gene region 3 (E3). The present invention also contemplates the use of the viral vectors for vaccination, gene therapy or other applications as suitable.
(FR)L'invention concerne des vecteurs viraux. Selon un mode de réalisation, cette invention concerne des adénovirus bovins recombinants et mutants ayant une délétion et/ou une insertion d'ADN dans la région 4 de gène précoce (E4). Selon un autre mode de réalisation, cette invention a trait à des virus d'adénovirus 1 bovins mutants et recombinants, possédant une délétion et/ou une insertion d'ADN dans la région 3 de gène précoce (E3). La présente invention porte également sur l'utilisation de vecteurs viraux dans le cadre de vaccination, de thérapie génique et d'autres applications dérivées.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, HR, HU, ID, IL, IN, IS, JP, KG, KR, KZ, LC, LK, LR, LT, LU, LV, MA, MD, MG, MK, MN, MX, NO, NZ, PL, PT, RO, RU, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, US, UZ, VN, YU, ZA.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)